Order Article Reprints

Ioannidis I, Lefkaritis G, Georgiades SN, Pashalidis I, Kontoghiorghes GJ. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues. International Journal of Molecular Sciences. 2024; 25(11):5954. https://doi.org/10.3390/ijms25115954

Ioannidis, Ioannis, George Lefkaritis, Savvas N. Georgiades, Ioannis Pashalidis, and George J. Kontoghiorghes. 2024. "Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues" International Journal of Molecular Sciences 25, no. 11: 5954. https://doi.org/10.3390/ijms25115954

Ioannidis, I., Lefkaritis, G., Georgiades, S. N., Pashalidis, I., & Kontoghiorghes, G. J. (2024). Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues. International Journal of Molecular Sciences, 25(11), 5954. https://doi.org/10.3390/ijms25115954